Phase 2 Trial Evaluates mRNA Influenza Vaccines' Safety and Immunogenicity in Adults
Could This New Vaccine Help Us Finally Beat the Flu?
This Phase 2 trial investigates the safety and immunogenicity of five mRNA-based influenza vaccines in 770 healthy adults.
Pfizer is testing new mRNA flu vaccines in healthy adults to see if they trigger a stronger immune response and reduce flu complications bet…
Dasatinib and Quercetin Show Promise in Improving Gait Speed in HIV-Associated Frailty
Can a New Drug Combination Help Older Adults with HIV Regain Strength?
Phase II trial of dasatinib and quercetin (D+Q) in 82 HIV+ frail/prefrail adults shows potential in improving gait speed.
A new trial tests if two drugs help older adults with HIV regain strength and walk better after years of frailty.
Rapid Diagnostics Align 65% of ICU Antibiotic Prescriptions with Pathogen Results
Why Are Doctors Hesitant to Trust Quick Test Results for Pneumonia?
In the INHALE RCT, 65% of ICU antibiotic prescriptions aligned with BioFire FilmArray Pneumonia Panel results.
When rapid pneumonia tests find no germs, doctors often ignore the result and keep prescribing antibiotics, risking longer hospital stays an…